Release Date: 28/06/22 09:59 Summary: Receipt of Non-Binding Indicative Offer from ALS Limited Price Sensitive: Yes Download Document 213.45KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market